Considering the increased risk of malignancy in patients with insulin resistance, largely attributed to elevated production of reactive oxygen species influencing carcinogenesis and mutagenesis, GLP-1 is believed to influence the development of malignancy by impeding this pathological pathway [39]. The gene discussed is GLP1R; the disease is Insulin resistance.